Timely Recovery After Subclinical Heart Failure
Conditions: Heart Failure; Diastolic Dysfunction Interventions: Drug: Perindopril Sponsors: Academisch Ziekenhuis Maastricht; ZonMw: The Netherlands Organisation for Health Research and Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Improving Psychological Outcomes for Acute Respiratory Failure Survivors Using a Self-Management Intervention
Conditions: Respiratory Failure; Anxiety; Critical Illness Interventions: Behavioral: Cognitive behavioral therapy based self-management for anxiety Sponsors: Johns Hopkins University; Francis Family Foundation; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Conditions: Breast Cancer Interventions: Drug: Dapagliflozin 10mg Tab Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Treatment According to Venous Excess Ultrasound Score in Patients With Heart Failure
Conditions: Heart Failure; Acute Kidney Injury Interventions: Other: VEXUS score; Diagnostic Test: NGAL Sponsors: Inonu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes
Conditions: Heart Failure Sponsors: Pr. Nicolas GIRERD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
Conditions: Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
Conditions: Heart Failure Interventions: Drug: HiCM-188 therapy Sponsors: Help Therapeutics; TEDA International Cardiovascular Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure Preserved Ejection Fraction; Pregnancy Complications Interventions: Diagnostic Test: Echocardiography; Other: Questionnaire Sponsors: National Medical Research Center for Therapy and Preventive Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Thailand ATTR-CM Registry
Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Interventions: Other: No intervention Sponsors: Mahidol University; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Conditions: Cardiotoxicity; Breast Cancer; Treatment Side Effects Interventions: Diagnostic Test: Plasma NT-proBNP Sponsors: Vastra Gotaland Region Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions
Conditions: Coronary Artery Disease Interventions: Device: DCB Angioplasty Sponsors: National Institute of Cardiovascular Diseases, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
Conditions: Cardiogenic Shock; Post-cardiac Surgery; Cardiac Arrest; Extracorporeal Membrane Oxygenation Complication; Infections Interventions: Diagnostic Test: Therapeutic drug monitoring of beta-lactam Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Atrial Fibrillation, Prevention and Rehabilitation
Conditions: Atrial Fibrillation; Prevention; Rehabilitation Interventions: Behavioral: Complex prevention and rehabilitation intervention Sponsors: Odense University Hospital; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Health Center, Municipality of Svendborg, Svendborg, Denmark.; Department of Internal Medicine& Emergency Department, Svendborg Hospital, Odense University Hospital, Svendborg, Denmark.; The Danish Heart Association, Funen, and local committee in Svendborg, Denmark Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Bioenergetic Effect of Pioglitazone in CLD-PH
Conditions: Pulmonary Hypertension; Pulmonary Hypertension (PH) Due to Chronic Lung Disease Interventions: Drug: Pioglitazone 30mg; Drug: Placebo; Diagnostic Test: Labs Sponsors: Emory University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes
Conditions: Heart Transplant Failure Interventions: Drug: Tacrolimus （FK506） Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
